Initially, we found FKBP10 and its molecular partner PLOD2, together with their potential substrate COL1A1 and COL1A2 presented a high-expression profile in ccRCC patients using a database that analyzes GEO datasets. Here, FKBP10 is linked to nonpapillary renal cell carcinoma.